Kare Schultz
Appearance
| Kåre Schultz | |
| Born | Kåre Schultz |
|---|---|
| Nationality | Danish |
| Occupation | Business executive |
| Employer | Hims & Hers Health (Board of Directors) |
| Known for | CEO of Teva Pharmaceutical Industries (2017–2023) |
Teva Pharmaceutical Industries,[1] [2] [3] H. Lundbeck A/S,[4] [4] [1] [1] [5] [6][7]Kenneth Frazier]] Richard Gonzalez Stéphane Bancel Mads Nipper
- ↑ 1.0 1.1 1.2 "Schultz kept Teva away from the abyss, but couldn't find a runway to growth". CTech. November 22, 2022. Retrieved 2026-02-24.
- ↑ "Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board". Hims & Hers Newsroom. July 22, 2024. Retrieved 2026-02-24.
- ↑ "Novo CEO's Shock Exit: Who Will Take Over Obesity Drug Giant?". Bloomberg.com. May 16, 2025. Retrieved 2026-02-24.
- ↑ 4.0 4.1 "Kåre Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017". Teva Pharmaceuticals. October 30, 2017. Retrieved 2026-02-24.
- ↑ "Teva Pharmaceutical to Replace CEO Kare Schultz". The Wall Street Journal. November 3, 2022. Retrieved 2026-02-24.
- ↑ "Teva seeks CEO replacement as Schultz plans to retire next year: WSJ". Fierce Pharma. November 4, 2022. Retrieved 2026-02-24.
- ↑ "Teva hires ex-Novartis executive to succeed CEO Schultz". Reuters. November 21, 2022. Retrieved 2026-02-24.